Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin.
J Am Acad Dermatol
; 89(2): 283-292, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37054814
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
J Am Acad Dermatol
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos